Durán, J., & Estrada, M. (2018). Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy. Front Pharmacol.
Citação norma ChicagoDurán, Javier, and Manuel Estrada. "Commentary: Blockade of Activin Type II Receptors With a Dual Anti-ActRIIA/IIB Antibody Is Critical to Promote Maximal Skeletal Muscle Hypertrophy." Front Pharmacol 2018.
MLA CitationDurán, Javier, and Manuel Estrada. "Commentary: Blockade of Activin Type II Receptors With a Dual Anti-ActRIIA/IIB Antibody Is Critical to Promote Maximal Skeletal Muscle Hypertrophy." Front Pharmacol 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.